Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
Completed · Phase 3 · Has a placebo group
Conditions studied: Diabetes Mellitus, Type 1
In brief
This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.
Key facts
- Study ID
- NCT00042458
- Run by
- AstraZeneca
- People needed
- 296
- Starts
- 2002-04-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2015-09-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HbA1c value between 7.5-9%
- Using multiple daily insulin injections
Where it is running
- Ana Ventures LLC — Mesa, Arizona, United States
- Phoenix Endocrinology Clinic, Ltd. — Phoenix, Arizona, United States
- East Bay Clinical Trial Center — Concord, California, United States
- Valley Research — Fresno, California, United States
- UCSD Diabetes Research Center — San Diego, California, United States
- Diabetes Research Institute — San Mateo, California, United States
- Sansum Medical Research Institute — Santa Barbara, California, United States
- Diablo Clinical Research — Walnut Creek, California, United States
- Barbara Davis Center for Childhood Diabetes — Denver, Colorado, United States
- MedStar Clinical Research Center — Washington D.C., District of Columbia, United States
- Medical Research Unlimited — Aventura, Florida, United States
- Medical Research Unlimited — Aventura, Florida, United States
- Internal Medicine Associates — Fort Myers, Florida, United States
- Suncoast Clinical Research — New Port Richey, Florida, United States
- Children's Clinic — Tallahassee, Florida, United States
- Atlanta Diabetes Associates — Atlanta, Georgia, United States
- St. James Diabetes Center — Chicago Heights, Illinois, United States
- St. James Diabetes Center — Chicago Heights, Illinois, United States
- Indiana University Outpatient Clinical Research — Indianapolis, Indiana, United States
- University of Maryland Joslin Diabetes Center — Baltimore, Maryland, United States
- Henry Ford Health System — Detroit, Michigan, United States
- Grand Rapids Associated Interns — Grand Rapids, Michigan, United States
- Radiant Research — St Louis, Missouri, United States
- Mercury Street Medical — Butte, Montana, United States
- UNC Diabetes Care Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.